Last reviewed · How we verify
Continuous interscalene nerve block
At a glance
| Generic name | Continuous interscalene nerve block |
|---|---|
| Also known as | Interscalene brachial plexus block |
| Sponsor | Mayo Clinic |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Continuous Cervical Erector Spinae Plane Block Versus Interscalene Nerve Block in Shoulder Arthroscopic Surgery (NA)
- Post Operative Infusion Pump Pain Study (PHASE4)
- Dose-Finding Study: MEV90 for Local Anesthetic in Interscalene Block for Supraclavicular Nerves Block (NA)
- Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block
- ISB With SSNB & ANB (NA)
- Ultrasound-guided Interscalene Brachial Plexus Block: Single Bolus Vs Continuous Catheter Placement in Arthroscopic Rotator Cuff Repair (NA)
- Liposomal Bupivacaine Single-Injection Interscalene Block vs. Continuous Interscalene Block for Primary Total Shoulder Arthroplasty (PHASE4)
- Efficacy of Nerve Blockade Performed Prior to Surgical Intervention Versus Following Surgical Intervention (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Continuous interscalene nerve block CI brief — competitive landscape report
- Continuous interscalene nerve block updates RSS · CI watch RSS
- Mayo Clinic portfolio CI